HSPH-Led Team Discovers Protective Cellular Process In ALS Disease In Mice, Hinting At New Therapeutic Approach

When Harvard School of Public Health (HSPH) scientists disabled a specific protein in mice that were genetically prone to develop ALS (Lou Gehrig's disease), they expected -- based on previous work -- to hasten the onset of the paralyzing, lethal disorder. What they found was the reverse.
This entry was posted in News from Other Sources. Bookmark the permalink. Both comments and trackbacks are currently closed.